SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist

By Anthes J.C.   Chapman R.W.   Richard C.   Eckel S.   Corboz M.   Hey J.A.   Fernandez X.   Greenfeder S.   McLeod R.   Sehring S.   Rizzo C.   Crawley Y.   Shih N.-Y.   Piwinski J.   Reichard G.   Ting P.   Carruthers N.   Cuss F.M.   Billah M.   Kreutner W.   Egan R.W.  

European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. : 191-202

Elsevier

Access to resources Recommend Favorite

Peripheral effects of three novel non-peptide tachykinin NK 1 receptor antagonists in the anaesthetized rat

By Cellier E.   Fayolle C.   Hipskind P.A.   Iyengar S.   Couture R.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 377-385

Elsevier

Access to resources Recommend Favorite

Effect of non-peptide tachykinin NK 1 receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea

By Khawaja A.M.   Liu Y.-C.   Rogers D.F.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 173-181

Elsevier

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 5, 1998-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

By Paranjape S.B.   Thibonnier M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 825-834

Informa Healthcare

Access to resources Recommend Favorite